Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating umbilical cord blood transplantation for hematologic cancers and related diseases has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Syndromes
• Thymic Carcinoma

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Graft Versus Host Disease, Leukemia | Phase 2 | Status: COMPLETED